Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
International Journal of Antimicrobial Agents|March 2, 2010
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!Leonard Amaral, Martin J Boeree, Stephen H Gillespie, et al.
Tropical Medicine & International Health : TM & IH|July 28, 2005
Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosisMartin J Boeree, Delphine Sauvageot, Hastings T Banda, et al.
Tropical Medicine & International Health : TM & IH|March 17, 2010
Childhood tuberculosis in the Kilimanjaro region: lessons from and for the TB programmeCharles M Mtabho, Constantine F Irongo, Martin J Boeree, et al.
Respiratory Medicine|September 27, 2017
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohortSanne Zweijpfenning, Stephan Kops, Cecile Magis-Escurra, et al.
International Journal of Antimicrobial Agents|November 22, 2011
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex diseaseJakko van Ingen, Sarah E Totten, Leonid B Heifets, et al.
Emerging Infectious Diseases|March 12, 2011
Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007Christof J Majoor, Cecile Magis-Escurra, Jakko van Ingen, et al.
Journal of Clinical Microbiology|February 18, 2011
Preferential deletion events in the direct repeat locus of Mycobacterium tuberculosisAnita C Schürch, Kristin Kremer, Albert Kiers, et al.
The Journal of Infection|September 8, 2009
Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patientsJakko van Ingen, Rina de Zwaan, Richard P N Dekhuijzen, et al.
Bulletin of the World Health Organization|September 8, 2011
Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot studyJossy van den Boogaard, Ramsey A Lyimo, Martin J Boeree, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical developmentJossy van den Boogaard, Gibson S Kibiki, Elton R Kisanga, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
International Journal of Antimicrobial Agents|March 2, 2010
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!Leonard Amaral, Martin J Boeree, Stephen H Gillespie, et al.
Tropical Medicine & International Health : TM & IH|July 28, 2005
Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosisMartin J Boeree, Delphine Sauvageot, Hastings T Banda, et al.
Tropical Medicine & International Health : TM & IH|March 17, 2010
Childhood tuberculosis in the Kilimanjaro region: lessons from and for the TB programmeCharles M Mtabho, Constantine F Irongo, Martin J Boeree, et al.
Respiratory Medicine|September 27, 2017
Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohortSanne Zweijpfenning, Stephan Kops, Cecile Magis-Escurra, et al.
International Journal of Antimicrobial Agents|November 22, 2011
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex diseaseJakko van Ingen, Sarah E Totten, Leonid B Heifets, et al.
Emerging Infectious Diseases|March 12, 2011
Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007Christof J Majoor, Cecile Magis-Escurra, Jakko van Ingen, et al.
Journal of Clinical Microbiology|February 18, 2011
Preferential deletion events in the direct repeat locus of Mycobacterium tuberculosisAnita C Schürch, Kristin Kremer, Albert Kiers, et al.
The Journal of Infection|September 8, 2009
Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patientsJakko van Ingen, Rina de Zwaan, Richard P N Dekhuijzen, et al.
Bulletin of the World Health Organization|September 8, 2011
Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot studyJossy van den Boogaard, Ramsey A Lyimo, Martin J Boeree, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical developmentJossy van den Boogaard, Gibson S Kibiki, Elton R Kisanga, et al.
Pageof 13